Early research (Phase 1)Study completedNCT00810303
What this trial is testing
Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Who this might be right for
PharmacokineticsDrug InteractionsPharmacodynamics+1 more
University Medicine Greifswald 12